Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Net Cash Flow: 2009-2025

Historic Net Cash Flow for Prestige Consumer Healthcare (PBH) over the last 16 years, with Sep 2025 value amounting to -$20.4 million.

  • Prestige Consumer Healthcare's Net Cash Flow fell 223.04% to -$20.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.7 million, marking a year-over-year increase of 741.32%. This contributed to the annual value of $52.0 million for FY2025, which is 526.13% up from last year.
  • As of Q3 2025, Prestige Consumer Healthcare's Net Cash Flow stood at -$20.4 million, which was down 149.99% from $40.8 million recorded in Q2 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Net Cash Flow ranged from a high of $131.6 million in Q2 2021 and a low of -$119.9 million during Q3 2021.
  • In the last 3 years, Prestige Consumer Healthcare's Net Cash Flow had a median value of $1.4 million in 2024 and averaged $2.9 million.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Net Cash Flow soared by 439.60% in 2021 and then plummeted by 587.34% in 2023.
  • Prestige Consumer Healthcare's Net Cash Flow (Quarterly) stood at -$21.6 million in 2021, then skyrocketed by 299.90% to $43.1 million in 2022, then tumbled by 95.05% to $2.1 million in 2023, then tumbled by 33.90% to $1.4 million in 2024, then plummeted by 223.04% to -$20.4 million in 2025.
  • Its Net Cash Flow stands at -$20.4 million for Q3 2025, versus $40.8 million for Q2 2025 and $46.9 million for Q1 2025.